Zinzino group revenue decreased with a total of 5%, compared with the previous year.
STOCKHOLM, May 4, 2022 /PRNewswire/ -- The revenue in April for Zinzino's sales markets decreased by 3% and amounted to SEK 95.4 (98.7) million. Faun Pharma's external sales decreased by 28% and amounted to SEK 5.6 (7.8) million. Overall, the Group decreased revenues by 5% to SEK 101.0 (106.5) million compared with the previous year.
Accumulated revenue for January April 2022 decreased by 1% to SEK 435.4 (439.9) million.
Revenues were distributed as follows:
Countries in regions:
- The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden
- Central Europe: Austria, Germany, Switzerland
- East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania
- South & West Europe: Cyprus, France, Greece, Italy, Netherlands, Spain, United Kingdom, Belgium, Ireland
- The Baltics: Estonia, Latvia, Lithuania
- North America: Canada, USA
- Asia-Pacific: Australia, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand
- Africa: South Africa
For more information:
Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, zinzino.com
Pictures for publication free of charge:
marketing@zinzino.com
Certified Adviser: Erik Penser Bank Aktiebolag, +46 (0) 8 463 83 00, email: certifiedadviser@penser.se
Zinzino AB (publ) is obliged to publish this information in compliance with current EU regulations governing market abuse. The information was provided by the above contact person for publication at 11:30 the 4rd of May 2022.
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/zinzino/r/zinzino-ab--publ--preliminary-sales-report-april-2022,c3559373
The following files are available for download: